| | Webinar: Signaling Pathway CDx for Therapy Response Prediction Wednesday, May 26, 2021 | 11am ET / 8am PT Learn how Philips and Qiagen are using mRNA technology in OncoSignal tests to quantify functional activity of disease-relevant signal transduction pathways in any cell and tissue type. This webinar will explore applications for both preclinical disease modeling and clinical measurement of response to targeted therapies and immunotherapies. Register Now. |
FDA rejects Biogen's subcutaneous Tysabri in multiple sclerosis Novartis hits setback in bid to block Regeneron's Eylea prefilled syringe as dual lawsuits drag on CSL taps HCmed to deliver immunoglobulins to the lungs Private equity firm buys PTS to seize on COVID-19-fueled transformation of nanoparticle delivery CANbridge buys liver-targeted gene therapies from LogicBio The top 20 drugs by worldwide sales in 2020 Featured Story | By Nick Paul Taylor The FDA has rejected Biogen’s request for approval of a subcutaneous formulation of Tysabri. Biogen suffered the setback shortly after receiving approval for the multiple sclerosis drug in the EU. read more |
| |
|---|
|
Top Stories By Angus Liu Novartis won’t be able to block Regeneron’s popular Eylea prefilled syringe any time soon after a regulatory setback with the U.S. International Trade Commission. But the Lucentis maker isn’t giving up on the patent fight that could shift the anti-VEGF competition between the two drugs. read more By Nick Paul Taylor CSL Behring has teamed up with HCmed to develop inhaled immunoglobulins. The collaborators are using HCmed’s AdheResp nebulizer platform to deliver plasma-derived immunoglobulins to the lungs of patients with respiratory conditions. read more By Nick Paul Taylor A private equity group has bought Polypeptide Therapeutic Solutions for its nanoparticle drug delivery technologies. Arcline Investment Management struck the deal in the belief the success of mRNA COVID-19 vaccines has permanently accelerated the rise of nanoparticle delivery. read more By Nick Paul Taylor CANbridge Pharmaceuticals has secured control of gene therapies based on LogicBio Therapeutics’ liver-targeting viral delivery capsid. The agreement gives CANbridge worldwide rights to gene therapy treatments for Fabry and Pompe diseases. read more By Eric Sagonowsky While the global sales rankings of Big Pharma's superstar drugs naturally feature the biggest names in the business, new meds often pop up or old drugs exit the scene. And the moves within the list from year to year illustrate many of the trends shaping pharma on a daily basis. read more Resources Sponsored By: Veeva Learn how to develop a standards program that has your full team’s buy-in and improves the efficiency and quality of your clinical trials. Sponsored By: Veeva One top 10 pharma outlines three key steps to launching a modular content strategy to generate localized content faster. Sponsored By: Blue Matter This 77-page e-book explores 7 keys to success that any biopharma company needs to keep in mind as it enters Europe. Sponsored by: Datacubed Health The average clinical trial spends $40,000 per patient. Yet despite these high costs, most trials struggle to retain patients. Sponsored By: AmerisourceBergen Developing a quality product and getting it approved for distribution is not enough to guarantee commercial success. Sponsored By: WCG Trifecta The new standards in study training help sponsors and CROs reduce costs by 60%, cut training time by 50%, and start enrollment 55 days faster – learn more today. Sponsored By: Oracle Health Sciences New research indicates an accelerated adoption of decentralized clinical trials due to COVID-19. Sponsored by: Cytiva A one-stop hub for Cytiva resources to support process intesification Sponsored By: August Bioservices How has COVID-19 impacted CRO/CDMO customer (dis)satisfaction and outsourcing decisions for pharma and biotech companies in 2021 and beyond? Sponsored by: Cytiva A one-stop hub for Cytiva resources to support process development and manufacturing of your novel molecule Sponsored by: PerkinElmer Informatics Discover the benefits of a cloud-native ELN that delivers better performance, security, connectivity, total cost of ownership PLUS sub-second search results through even the largest data volumes. Sponsored By: Remarque Systems Remarque Systems consolidates data, then layers on visualization and automated metrics to generate consistent, actionable data insights in real-time. Click here for more info. Sponsored By: BC Platforms Those wishing to unlock RWD’s true value must have access to a variety of data sources/types and the technological capabilities to use the data to uncover meaningful insights. Sponsored By: Oracle Health Sciences New research indicates an accelerated adoption of decentralized clinical trials due to COVID-19. Sponsored By: Within3 We enable virtual work — offering over-time sessions where participants are more focused, insights are more diverse and business goals are met. Sponsored by: Catalent Discover the current state of patient-focused dose design through clinical evidence, real-world case studies and patient preference-driven drug design solutions that can help develop better treatments and successful real-world outcomes. Sponsored by: Catalent This eBook features insights from experts in the industry on patient-centric drug development challenges and strategies on advancing drug design and development effectively. Sponsored by: Catalent Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and more during the drug product process development phase. Sponsored by: Catalent In this webinar, pharmaceutical scientists present real-life examples of challenges they’ve overcome in the transfer of oral small molecules from a dedicated early-phase development site to a dedicated late-phase manufacturing site. Medical Affairs Strategic Summit (MASS) Virtual May 5-7, 2021 | Virtual Event TMF Virtual Summit May 18-20, 2021 | Virtual Event | 